H.C. Wainwright lowered the firm’s price target on Zura Bio (ZURA) to $2 from $3 and keeps a Neutral rating on the shares. The firm updated the company’s model post the Q2 report to reflect increases in potentially dilutive shares outstanding.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZURA: